Endurance Performance: Genes or Gene Combinations?

F. Gómez-Gallego,C. Santiago,M. Gonzalez-Freire,Carlos A. Muniesa,M. F. D. Valle,Margarita Pérez,C. Foster,A. Lucia

DOI: https://doi.org/10.1055/s-2008-1038677

2008-07-23

International Journal of Sports Medicine

Abstract:ACE ACTN3 ACE ACTN3 ACTN3 ACTN3 ACE ACTN3 ACTN3/ACE

What problem does this paper attempt to address?

Advances in the diagnosis of sickle cell retinopathy

Raeba Mathew,Sobha Sivaprasad

DOI: https://doi.org/10.1080/17469899.2018.1523007

2018-09-03

Expert Review of Ophthalmology

Abstract:Introduction: Sickle cell disease (SCD) is an occlusive vascular disease that affects the vasculature of any part of the body including retina. Although the proliferative form of sickle cell retinopathy (SCR) may be more potentially damaging leading to visual impairment, non-proliferative forms too manifest changes in macula and peripheral retina. Advances in management of systemic complications of SCD have improved patient survival into adulthood with better quality of life leading to increased frequency of all ocular complications. Hence regular screening and early diagnosis of SCR is important to forestall visually significant complications of the same. Areas covered: This article gives a review of recent advances in structural and functional diagnostic imaging modalities such as spectral domain optical coherence tomography (OCT), wide-field retinal fundus photography/angiography, OCT angiography, microperimetry, electroretinography, and multimodal imaging in assessment of SCR. A literature search was conducted on PubMed on diagnostic modalities in SCR. Considering rarity of the condition, large population studies are not available therefore articles on small studies and case series are also included. Expert opinion: Multimodal imaging allows a comprehensive evaluation of the central and peripheral features of SCR. This helps in early diagnosis of complications and timely intervention for effective management.
Advances in sickle cell retinopathy screening techniques, tests, and practices: A systematic review

Olivia W. Cummings,Sara Rahman,Lauren Fletcher,Adrienne W. Scott

DOI: https://doi.org/10.1002/ajh.27439

IF: 13.265

2024-07-25

American Journal of Hematology

Abstract:Sickle cell retinopathy (SCR) is a progressive, sight‐threatening ophthalmic complication of sickle cell disease (SCD). Current SCR screening focuses on the detection of pathologic sea fan neovascularization, the first sign of proliferative sickle cell retinopathy (PSR). If untreated, PSR can lead to severe visual impairment and blindness through progression to vitreous hemorrhage and/or retinal detachment. SCR screening with dilated fundus examination (DFE) is recommended every 1–2 years starting at age 10, but data underlying this recommendation are of poor quality and based upon expert consensus. We performed a systematic review to characterize imaging techniques, laboratory‐based tests, and clinical practices for SCR screening. This PROSPERO‐registered systematic review included relevant texts identified through predetermined searches in online databases. Collected test accuracy data facilitated the calculation of likelihood ratios. Forty‐four studies evaluating 4928 patients were included. DFE demonstrated moderate test accuracy (LR+ of 8.0, LR‐ of 0.3). Ultra‐widefield‐fundus photography demonstrated superior accuracy (LR+ 32.5, LR‐ 0.03). Optical coherence tomography angiography applications were highly accurate for PSR identification (machine learning LR+ 32.5, LR‐ 0.03; human grader LR+ 2.8–213.1, LR‐ 0.1‐0.2). Most techniques and tests were more accurate at detecting PSR than staging SCR or detecting lower‐grade SCR. Our findings support the integration of advanced image‐based approaches, such as computer‐based image analysis and ultra‐wide‐field fundus imaging, for SCR screening in SCD patients given the superior accuracy in PSR detection compared with the current standard of care. Rigorous SCR screening implementation studies are needed to support evidence‐based SCR screening recommendations.

hematology
Sickle Eye Project: a cross-sectional, non-interventional study of the prevalence of visual impairment due to sickle cell retinopathy and maculopathy in the UK

Christiana Dinah,Konstantinos Balaskas,Brigit Greystoke,Rossby Awadzi,Peter Beke,Roger Ahern,James Talks

DOI: https://doi.org/10.1136/bmjopen-2023-082471

IF: 3.006

2024-02-28

BMJ Open

Abstract:Introduction: Sickle cell disease (SCD) is one of the most common genetic disorders in the UK, with over 15 000 people affected. Proliferative sickle cell retinopathy (SCR) is a well-described complication of SCD and can result in significant sight loss, although the prevalence in the UK is not currently known. There are currently no national screening guidelines for SCR, with wide variations in the management of the condition across the UK. Methods and analysis: The Sickle Eye Project is an epidemiological, cross-sectional, non-interventional study to determine the prevalence of visual impairment due to SCR and/or maculopathy in the UK. Haematologists in at least 16 geographically dispersed hospitals in the UK linked to participating eye clinics will offer study participation to consecutive patients meeting the inclusion criteria attending the sickle cell clinic. The following study procedures will be performed: (a) best corrected visual acuity with habitual correction and pinhole, (b) dilated slit lamp biomicroscopy and funduscopy, (c) optical coherence tomography (OCT), (d) OCT angiography where available, (e) ultrawide fundus photography, (f) National Eye Institute Visual Function Questionnaire-25 and (g) acceptability of retinal screening questionnaire. The primary outcome is the proportion of people with SCD with visual impairment defined as logarithm of the minimum angle of resolution ≥0.3 in at least one eye. Secondary outcomes include the prevalence of each stage of SCR and presence of maculopathy by age and genotype; correlation of stage of SCR and maculopathy to severity of SCD; the impact of SCR and presence of maculopathy on vision-related quality of life; and the acceptability to patients of routine retinal imaging for SCR and maculopathy. Ethics and dissemination: Ethical approval was obtained from the South Central-Oxford A Research Ethics Committee (REC 23/SC/0363). Findings will be reported through academic journals in ophthalmology and haematology.
Attenuation of infectious bursal disease virus and vaccination trials under laboratory and field conditions.

A. Rinaldi,D. Cessi,G. Cervio,E. Lodetti

DOI: https://doi.org/10.1080/03079457409353815

Avian Pathology

Abstract:Adaptation to the chicken embryo of a virus strain of infectious bursal disease resulted in a reduction in virulence. After 60 passages the strain was attenuated enough to be used as a vaccine. The attenuation proved adequately stable. If given orally in the drinking water, the strain induced the development of neutralising and precipiting antibodies and a strong resistance against the disease. Promising results have also been obtained in the field.
The Impact of Optical Coherence Tomography in the Early Identification of Children with Sickle Cell Retinopathy

Ashraf Abdelkader,Mohamed Shaaban,Mahmoud M Zahran,Mostafa F Mohammed,Anas M Ebrahim,Ahmed I Galhoom

DOI: https://doi.org/10.1155/2022/9131423

2022-08-29

Abstract:Introduction: Sickle cell disease is characterized by the production of abnormal hemoglobin, which affects hemoglobin molecule stability during hypoxia and leads to the formation of sickle cells, resulting in increased hematic viscosity, hemolysis, and microvascular blockage. Vasoocclusion is assumed to be the primary cause of vision-threatening retinopathy in sickle cell disease. The aim of this study was to improve the early detection of sickle cell retinopathy (SCR) in children with sickle cell disease (SCD) and investigate the link between systemic and ocular symptoms. Methods: This cross-sectional study comprised children with SCD. The patient files provided a detailed medical history. The laboratory tests included a blood count, reticulocyte count, and Hb electrophoresis. The slit lamp, fundus, optical coherence tomography (OCT), and optical coherence tomography angiography (OCTA) were all part of the ophthalmological examination. Results: The study comprised 15 children with sickle cell disease who met the inclusion and exclusion criteria, with a mean age of 11.15 ± 1.29 years. Nine of the children were males (60%) and six were females (40%). 8 (53.3%) of the children had Hb SS, three (20%) had Hb SC, three (20%) had Hb SB+, and one (6.7%) had Hb SB0. Four children (26.7%) had poor visual acuity. A fundus examination revealed significant abnormal findings in 12 of the 7 children's eyes (40 percent). Macular thinning was detected by OCT in 10 eyes of 7 children (33.3%). Flow voids at the deep retinal capillary plexus were detected by OCTA in 10 eyes of 7 children (33.3%). Longer disease duration, higher reticulocytic percent, more painful crises, and noncompliance with hydroxyurea medication were all linked to the existence of eye abnormalities on fundus examination and OCT. Conclusion: OCTA can show early retinal damage in sickle cell patients with macular changes. Sickle cell retinopathy is usually associated with more severe disease.
Systemic medications for sickle cell disease and potential applications for sickle cell retinopathy

Anupam K. Garg,Adrienne W. Scott

DOI: https://doi.org/10.1097/icu.0000000000001041

2024-03-23

Current Opinion in Ophthalmology

Abstract:Purpose of review To review the literature evaluating systemic medications for treatment of sickle cell disease (SCD) and their applications for sickle cell retinopathy. Recent Findings Prior studies have demonstrated the efficacy of traditional systemic therapies in reducing the risk of development of sickle cell retinopathy. Since 2017, several new and promising disease-modifying therapies for sickle cell disease have been approved for clinical use, including the first genetic therapies such as exagamglogene autotemcel (exa-cel) and lovotibeglogene autotemcel (lovo-cel). These treatments have shown promising results for systemic management but are not widely utilized due to limited access and high cost. The efficacy of these therapies for the prevention of sickle cell retinopathy remains unknown and opens the door to new avenues for research. Furthermore, the role of systemic therapy for the management of hemoglobin SC (HbSC) disease, which has milder systemic effects but higher likelihood of causing retinopathy, remains poorly understood. Summary Hydroxyurea has been a mainstay of systemic management of SCD with prior work suggesting its ability to reduce the likelihood of developing retinopathy. There are several new and potentially curative systemic therapies for SCD, though their role in retinopathy prevention and management has not been studied extensively. Future studies are necessary to understand the implications of these emerging therapies for sickle cell retinopathy.

ophthalmology
Macular neurodegenerative and vascular changes on OCTA in sickle cell disease are not related to its ocular and systemic complications

Rajani P Brandsen,Bart J Biemond,Gulsum Z Nasim,Erfan Nur,Reinier O Schlingemann,Roselie M H Diederen

DOI: https://doi.org/10.1097/IAE.0000000000004247

2024-08-13

Retina

Abstract:Purpose: To evaluate macular abnormalities in sickle cell disease (SCD) with OCT-Angiography (OCTA) and to determine associations with sickle cell retinopathy (SCR) and clinical and laboratory characteristics. Methods: Complete ophthalmic examination was performed in consecutive SCD patients (HbSS, HbSC, HbSβ0 or HbSβ+ genotype), including fundoscopy and macular SD-OCT/OCTA scans. SCR stage was based on fundoscopic examination (without fluorescein angiography) instead of the Goldberg classification, since fluorescein angiography was only used in case of tentative diagnosis. Medical/ophthalmological history and hematologic characteristics were retrieved from medical records. Results: 249 eyes of 137 patients were analyzed. The mean age was 33.3 ± 12.4 years (range 15-70). Non-proliferative SCR was present in 57 eyes (22.9%) and proliferative SCR in 36 eyes (14.5%). Macular thinning was present in 100 eyes (40.2%) and was associated with lower foveal vessel density (VD) of the superficial capillary plexus (SCP) and deep capillary plexus (DCP) and with enlargement of the foveal avascular zone (FAZ) area, perimeter and acircularity index (AI). Age and female sex were associated with lower (para)foveal VD in the SCP and DCP. No associations were found between SCR presence/severity and macular thinning or VD. Conclusion: Macular abnormalities were common, but did not result in visual impairment. No relation with SCR presence/severity was found. While OCTA-imaging is suitable for detecting maculopathy, it appears to have no diagnostic value in identifying patients at risk for SCR.
Structural basis for pulmonary functional imaging.

H. Itoh,Masashi Nakatsu,L. Yoxtheimer,H. Uematsu,Y. Ohno,H. Hatabu

DOI: https://doi.org/10.1016/S0720-048X(00)00301-6

IF: 4.531

2001-03-01

European Journal of Radiology

Abstract:
The behavioural effects of intrathecally administered [d-PRO2,d-TRP7,9]-substance P, an analogue with presumed antagonist actions, in the rat

R. E. Roudriguez,T. Salt,P. Cahusac,R. Hill

DOI: https://doi.org/10.1016/0028-3908(83)90005-9

IF: 5.273

1983-02-01

Neuropharmacology

Abstract:
Standardization of coding definitions for sickle cell disease complications: A systematic literature review

Paulette Negron Ericksen,Firas Dabbous,Rajrupa Ghosh,Surbhi Shah,Xunming Sun,Emily Riehm Meier,Carmine Colavecchia

DOI: https://doi.org/10.1002/pds.5769

2024-09-01

Pharmacoepidemiology and Drug Safety

Abstract:Purpose Sickle cell disease (SCD) affects all organ systems and is characterized by numerous acute and chronic complications and comorbidities. Standardized codes are needed for complications/comorbidities used in real‐world evidence (RWE) studies that rely on administrative and medical coding. This systematic literature review was conducted to produce a comprehensive list of complications/comorbidities associated with SCD, along with their diagnosis codes used in RWE studies. Methods A search in MEDLINE and Embase identified studies published from 2016 to 2023. Studies were included if they were conducted in US SCD populations and reported complications/comorbidities and respective International Classification of Diseases, Clinical Modification (ICD‐CM) codes. All identified complications/comorbidities and codes were reviewed by a certified medical coding expert and hematologist. Results Of 1851 identified studies, 39 studies were included. The most reported complications/comorbidities were stroke, acute chest syndrome, pulmonary embolism, venous thromboembolism, and vaso‐occlusive crisis. Most of the studies used ICD‐9‐CM codes (n = 21), while some studies used ICD‐10‐CM codes (n = 3) or both (n = 15), depending on the study period. Most codes reported in literature were heterogeneous across complications/comorbidities. The medical coding expert and hematologist recommended modifications for several conditions. Conclusion While many studies we identified did not report their codes and were excluded from this review, the studies with codes exhibited diverse coding definitions. By providing a standardized set of diagnosis codes that were reported by studies and reviewed by a coding expert and hematologist, our review can serve as a foundation for accurately identifying complications/comorbidities in future research, and may reduce heterogeneity, enhance transparency, and improve reproducibility. Future efforts focused on validating these code lists are needed.

pharmacology & pharmacy,public, environmental & occupational health
Early diagnosis of sickle cell retinopathy by using ocular coherence tomography in pediatric population (7–18 years) in central India

Pooja Soni,Bhavna Dhingra,Samendra Karkhur,Narendra K. Chaudhary,Abhijit P. Pakhare

DOI: https://doi.org/10.1002/pbc.31021

2024-04-23

Pediatric Blood & Cancer

Abstract:Background Sickle cell disease (SCD) is the commonest inherited blood disorder leading to complications occurring due to vaso‐occlusion including sight‐threatening retinopathy. Retinopathy can be managed if diagnosed early and vision loss can be prevented. Since, very less data are available from India, hence, this study was conducted in children (7–18 years) with SCD to diagnose retinopathy by using ocular coherence tomography (OCT) in subclinical stages. Methods This cross sectional single‐center study was performed in 7–18 years age group children with SCD without any visual symptoms. Enrolled participants underwent complete ophthalmological examination including macula and optic disc thickness measurements using Cirrus HD‐OCT and results were analyzed. Results Among 55 participants, none had visual impairment. Significant fundoscopy finding (nonproliferative sickle cell retinopathy/NPSR) was found in three patients (5.4%), thinning of central macula in four patients (7.27%), inner macula thinning in eight patients (14.5%), outer macula thinning in one patient (1.81%), retinal nerve fiber layer thinning in five patients (9%), ganglion cell layer to inner plexiform layer thinning in eight patients (14.54%). Overall NPSR was found in 5.4% patients detected with fundoscopy, whereas retinal layer thinning was found in 14 patients (25.4%) using OCT. Conclusion Despite of the significant prevalence of SCR, it is still underdiagnosed complication, leading to thinning of the retina from early ages; thus, its early diagnosis by regular screening using newer diagnostic methods can prevent progression to sight‐threatening complications and provide better quality of life for these patients.

oncology,pediatrics,hematology
Laser therapy for retinopathy in sickle cell disease

Kay Thi Myint,Soumendra Sahoo,Aung Win Thein,Soe Moe,Han Ni

DOI: https://doi.org/10.1002/14651858.CD010790.pub3

2022-12-12

Abstract:Background: Sickle cell disease (SCD) includes a group of inherited haemoglobinopathies affecting multiple organs including the eyes. Some people with SCD develop ocular manifestations. Vision-threatening complications are mainly due to proliferative sickle retinopathy, which is characterised by proliferation of new blood vessels. Laser photocoagulation is widely applicable in proliferative retinopathies. It is important to evaluate the efficacy and safety of laser photocoagulation in the treatment of proliferative sickle retinopathy (PSR) to prevent sight-threatening complications. Objectives: To evaluate the effectiveness of various techniques of laser photocoagulation therapy in SCD-related proliferative retinopathy. Search methods: We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group's Haemoglobinopathies Trials Register, compiled from electronic database searches and handsearching of journals and conference abstract books. Date of last search: 4 July 2022. We also searched the following resources (26 June 2022): Latin American and Caribbean Health Science Literature Database (LILACS); WHO International Clinical Trials Registry Platforms (ICTRP); and ClinicalTrials.gov. Selection criteria: Randomised controlled trials comparing laser photocoagulation to no treatment in children and adults with SCD. Data collection and analysis: Two review authors independently assessed eligibility and risk of bias of the included trials; we extracted and analysed data, contacting trial authors for additional information. We assessed the certainty of the evidence using the GRADE criteria. Main results: We included three trials (414 eyes of 339 children and adults) comparing the efficacy and safety of laser photocoagulation to no therapy in people with PSR. There were 160 males and 179 females ranging in age from 13 to 67 years. The trials used different laser photocoagulation techniques; one single-centre trial employed sectoral scatter laser photocoagulation using an argon laser; a two-centre trial employed feeder vessel coagulation using argon laser in one centre and xenon arc in the second centre; while a third trial employed focal scatter laser photocoagulation using argon laser. The mean follow-up periods were 21 to 32 months in one trial, 42 to 47 months in a second, and 48 months in the third. Two trials had a high risk of allocation bias due to the randomisation method for participants with bilateral disease; the third trial had an unclear risk of selection bias. One trial was at risk of reporting bias. Given the unit of analysis is the eye rather than the individual, we chose to report the data narratively. Using sectoral scatter laser photocoagulation, one trial (174 eyes) reported no difference between groups for complete regression of PSR: 30.2% in the laser group and 22.4% in the control group. The same trial also reported no difference between groups in the development of new PSR: 34.3% of lasered eyes and 41.3% of control eyes (very low-certainty evidence). The two-centre trial using feeder vessel coagulation, only presented data at follow-up for one centre (mean period of nine years) and reported the development of new sea fan in 48.0% in the treated and 45.0% in the control group; no statistical significance (P = 0.64). A third trial reported regression in 55% of the laser group versus 28.6% of controls and progression of PSR in 10.5% of treated versus 25.7% of control eyes. We graded the evidence for these two primary outcomes as very low-certainty evidence. The sectoral scatter laser photocoagulation trial reported visual loss in 3.0% of treated eyes (mean follow-up 47 months) versus 12.0% of controlled eyes (mean follow-up 42 months) (P = 0.019). The feeder vessel coagulation trial reported visual loss in 1.14% of the laser group and 7.5% of the control group (mean follow-up 26 months at one site and 32 months in another) (P = 0.07). The focal scatter laser photocoagulation trial (mean follow-up of four years) reported that 72/73 eyes had the same visual acuity, while visual loss was seen in only one eye from the control group. We graded the certainty of the evidence as very low. The sectoral scatter laser trial detected vitreous haemorrhage in 12.0% of the laser group and 25.3% of control with a mean follow-up of 42 (control) to 47 months (treated) (P ≤ 0.5). The two-centre feeder vessel coagulation trial observed vitreous haemorrhage in 3.4% treated eyes (mean follow-up 26 months) versus 27.5% control eyes (mean follow-up 32 months); one centre (mean follow-up nine years) reported vitreous haemorrhage in 1/25 eyes (4.0%) in the treatment group and 9/20 eyes (45.0%) in the control group (P = 0.002). The scatter laser photocoagulation trial reported that vitreous haemorrhage was not seen in the treated group compared to 6/35 (17.1%) eyes in the control group and appeared only in the grades B and (PSR) stage III) (P < 0.05). We graded evidence for this outcome as low-certainty. Regarding adverse effects, only one occurrence of retinal tear was reported. All three trials reported on retinal detachment, with no significance across the treatment and control groups (low-certainty evidence). One trial reported on choroidal neovascularization, with treatment with xenon arc found to be associated with a significantly higher risk, but visual loss related to this complication is uncommon with long-term follow-up of three years or more. The included trials did not report on other adverse effects or quality of life. Authors' conclusions: Our conclusions are based on the data from three trials (two of which were conducted over 30 years ago). Given the limited evidence available, which we assessed to be of low- or very low-certainty, we are uncertain whether laser therapy for sickle cell retinopathy improves the outcomes measured in this review. This treatment does not appear to have an effect on clinical outcomes such as regression of PSR and development of new incidences. No evidence is available assessing efficacy in relation to patient-important outcomes (such as quality of life or the loss of a driving licence). Further research is needed to examine the safety of laser treatment compared to other interventions such as intravitreal injection of anti-vascular endothelial growth factors (VEGFs) . Patient-important outcomes as well as cost-effectiveness should be addressed.
Optical Coherence Tomography Angiography of Macular Microangiopathy in Children With Sickle Cell Disease

Enass H. Raffa,Lina Raffa,Samara Almadani,Wesal Murad,Hawazin Alshanti

DOI: https://doi.org/10.1097/mph.0000000000002934

2024-09-27

Journal of Pediatric Hematology/Oncology

Abstract:In this study, we identified the presence of sickle cell maculopathy and determined correlations between hemolysis indicators and systemic and ocular manifestations in children with sickle cell disease (SCD). Thirty-three patients with SCD 5 to 18 years of age underwent optical coherence tomography angiography (OCTA) as part of a thorough eye examination. The hematological indices and clinical data (hemoglobin, fetal hemoglobin, mean corpuscular volume, and frequency of sickle cell-associated complications and therapy) were collected. The SCD group contained 33 patients (66 eyes), and the control group contained 36 healthy participants (72 eyes). The SCD group had significantly thinner parafoveal thickness ( P =0.041) and significantly smaller parafoveal volume ( P =0.041) than the controls. The SCD group had lower deep capillary plexus density than the controls ( P =0.029). The SCD group had significantly smaller flow areas than the controls ( P <0.001). The foveal avascular zone (FAZ) perimeter, foveal density, and FAZ area in the entire retina did not differ significantly between the groups ( P >0.05). The platelet level was negatively correlated with parafoveal and perifoveal thickness and density. OCTA detected early macular microvascular changes in children and adolescents with asymptomatic SCD.

oncology,pediatrics,hematology
A dual-band adaptor for infrared imaging.

A. Mclean,J. Ahn,R. Maingi,T. Gray,A. Roquemore

DOI: https://doi.org/10.1063/1.4717672

IF: 1.6

2012-05-21

Review of Scientific Instruments

Abstract:A novel imaging adaptor providing the capability to extend a standard single-band infrared (IR) camera into a two-color or dual-band device has been developed for application to high-speed IR thermography on the National Spherical Tokamak Experiment (NSTX). Temperature measurement with two-band infrared imaging has the advantage of being mostly independent of surface emissivity, which may vary significantly in the liquid lithium divertor installed on NSTX as compared to that of an all-carbon first wall. In order to take advantage of the high-speed capability of the existing IR camera at NSTX (1.6-6.2 kHz frame rate), a commercial visible-range optical splitter was extensively modified to operate in the medium wavelength and long wavelength IR. This two-band IR adapter utilizes a dichroic beamsplitter, which reflects 4-6 μm wavelengths and transmits 7-10 μm wavelength radiation, each with >95% efficiency and projects each IR channel image side-by-side on the camera's detector. Cutoff filters are used in each IR channel, and ZnSe imaging optics and mirrors optimized for broadband IR use are incorporated into the design. In-situ and ex-situ temperature calibration and preliminary data of the NSTX divertor during plasma discharges are presented, with contrasting results for dual-band vs. single-band IR operation.
RETINAL OPTICAL COHERENCE TOMOGRAPHY IMAGING BIOMARKERS: A Review of the Literature

Bhadra U Pandya,Michael Grinton,Efrem D Mandelcorn,Tina Felfeli

DOI: https://doi.org/10.1097/IAE.0000000000003974

2024-03-01

Retina

Abstract:Purpose: The aim of this literature review was to summarize novel optical coherence tomography (OCT) imaging biomarkers that have recently been described in the literature and are frequently encountered clinically. Methods: The literature was reviewed to identify novel OCT biomarkers reported to date. A descriptive summary of all terms and representative illustrations were provided to highlight the most relevant features. Results: Thirty-seven OCT terminologies were identified. The vitreomacular interface disorder group included the four stages of epiretinal membrane, macular pseudohole, tractional lamellar hole (LH), degenerative LH, cotton ball sign, and foveal crack sign. The age-related macular degeneration group included outer retinal tubulation, multilayered pigment epithelial detachment, prechoroidal cleft, onion sign, double-layer sign, complete outer retinal atrophy, complete retinal pigment epithelium and outer retinal atrophy, and reticular pseudodrusen. The uveitic disorder group consisted of bacillary layer detachment, syphilis placoid, rain-cloud sign, and pitchfork sign. The disorders relating to the toxicity group included flying saucer sign and mitogen-activated protein kinase (MEK) inhibitor-associated retinopathy. The disorders associated with the systemic condition group included choroidal nodules and needle sign. The pachychoroid spectrum group included pachychoroid and brush border pattern. The vascular disorder group included pearl necklace sign, diffuse retinal thickening, disorganization of retinal inner layers, inner nuclear layer microcysts, hyperreflective retinal spots, paracentral acute middle maculopathy, and acute macular neuroretinopathy. The miscellaneous group included omega sign (ω), macular telangiectasia (type 2), and omega sign (Ω). Conclusions: Thirty-seven OCT terminologies were summarized, and detailed illustrations consolidating the features of each biomarker were included. A nuanced understanding of OCT biomarkers and their clinical significance is essential because of their predictive and prognostic value.
Proliferative Sickle Cell Retinopathy: A Patient and a Physician's Perspective on Quality of Life and Quality of Eye Care

Chanel Taylor,Rossby Awadzi,Jamie Enoch,Christiana Dinah

DOI: https://doi.org/10.1007/s40123-024-00893-3

2024-02-13

Ophthalmology and Therapy

Abstract:The impact of visual impairment in the context of sickle cell disease is poorly understood. Despite the significant advancements over the past three decades in retinal imaging and in the understanding of molecular mechanisms that drive retinal neovascularization, there has been little improvement in the management of proliferative sickle cell retinopathy. This article is co-authored by a patient impacted by proliferative sickle cell retinopathy. She highlights her personal experience of sight loss from proliferative sickle cell retinopathy and the impact on her daily life and mental health. Subsequent to diagnosis and management of proliferative sickle cell retinopathy, she continues to live with irreversible sight loss and provides crucial insight from a patient's perspective into the broad lack of high-quality educational materials online and lack of understanding of the disease within the clinical community. This article aims to provide a strong narrative to emphasize the need for further qualitative and quantitative research in this area, to bring about the holistic step-change required to improve visual outcomes and eyecare for people with sickle cell disease.

ophthalmology
It Ain’t What You Do, It’s the Way that You Do It! Teaching Style Affects Children’s Motivation in Track and Field Lessons

M. Goudas,S. Biddle,K. Fox,M. Underwood

DOI: https://doi.org/10.1123/TSP.9.3.254

1995-09-01

Abstract:The purpose of this study was to examine the motivational effects of two different teaching styles in one sport activity. One class of 24 girls was taught track and field for 10 weeks, each lesson being taught with either a direct (practice) or a differentiated (inclusion) teaching style. After each lesson the girls completed self-report measures of intrinsic motivation and goal involvement. On course completion, 8 girls were interviewed to assess their reactions to the course. ANOVA showed that students reporting higher levels of competence, autonomy, and task orientation had higher intrinsic motivation scores throughout the course. However, teaching style was also found to have an independent effect; the differentiated style was associated with higher levels of intrinsic motivation and task goal involvement and lower levels of work avoidance involvement. A differentiated teaching style can positively influence young girls’ reactions to a sports activity independently of perceptions of goal orientations,...
Red Blood Cell Sphericity Index Obtained by Defocusing Microscopy and Retinopathy Severity in Sickle Cell Disease

Camilo Brandao-de-Resende,Ubirajara Agero,Oscar N. Mesquita,Livia S. Gomes,Daniel V. Vasconcelos-Santos

DOI: https://doi.org/10.48550/arXiv.2112.08238

2021-12-15

Applied Physics

Abstract:Proliferative sickle cell retinopathy (PSCR) is the most important ocular manifestation of sickle cell disease (SCD), but understanding of its pathophysiology remains incomplete. Red blood cell (RBC) deformability has been identified as a critical factor in SCD and is intrinsically related with cell sphericity index (SI). The aim of this study was to develop an algorithm that automatically analyzes defocusing microscopy (DM) images, providing biomechanical parameters of individual RBCs, including cellular SI. Furthermore, association of RBC SI with severity of PSCR in individuals with HbSC-SCD was also investigated. We determined the SI of 255 RBCs from 17 individuals using DM. Nine individuals (53%) were healthy and eight (47%) had HbSC-SCD. Mean SI was significantly lower in SCD than in control group (0.69 versus 0.73), and also in severe than in mild PSCR (0.67 versus 0.70). Lower SI was also associated with more severe retinopathy (ROC AUC = 0.85) and the proportion of participants with SI <= 0.69 was significantly greater in severe than in mild PSCR (100% versus 25%). In conclusion, lower RBC SI determined by DM was associated not only with the presence of SCD, but also with more severe PSCR, possibly being a surrogate biomarker of disease severity.
[THE TREATMENT OF DELIRIUM TREMENS].

J. Vedrinne,B. Schott

Abstract:
Surgical Outcomes In Concurrent Sickle Cell And Diabetic Retinopathy

Landon J. Rohowetz,Abdulla Shaheen,Maria Magraner,Harry W. Flynn,Basil K. Williams,William E. Smiddy,Jayanth Sridhar,Jonathan F. Russell,Justin H. Townsend,Audina M. Berrocal,Thomas Albini,Nicolas A. Yannuzzi

DOI: https://doi.org/10.1097/iae.0000000000004156

2024-08-23

Retina

Abstract:To report the clinical features and outcomes in eyes that underwent vitreoretinal surgery for complications of concurrent sickle cell retinopathy and diabetic retinopathy.

ophthalmology

Endurance Performance: Genes or Gene Combinations?

Advances in the diagnosis of sickle cell retinopathy

Advances in sickle cell retinopathy screening techniques, tests, and practices: A systematic review

Sickle Eye Project: a cross-sectional, non-interventional study of the prevalence of visual impairment due to sickle cell retinopathy and maculopathy in the UK

Attenuation of infectious bursal disease virus and vaccination trials under laboratory and field conditions.

The Impact of Optical Coherence Tomography in the Early Identification of Children with Sickle Cell Retinopathy

Systemic medications for sickle cell disease and potential applications for sickle cell retinopathy

Macular neurodegenerative and vascular changes on OCTA in sickle cell disease are not related to its ocular and systemic complications

Structural basis for pulmonary functional imaging.

The behavioural effects of intrathecally administered [d-PRO2,d-TRP7,9]-substance P, an analogue with presumed antagonist actions, in the rat

Standardization of coding definitions for sickle cell disease complications: A systematic literature review

Early diagnosis of sickle cell retinopathy by using ocular coherence tomography in pediatric population (7–18 years) in central India

Laser therapy for retinopathy in sickle cell disease

Optical Coherence Tomography Angiography of Macular Microangiopathy in Children With Sickle Cell Disease

A dual-band adaptor for infrared imaging.

RETINAL OPTICAL COHERENCE TOMOGRAPHY IMAGING BIOMARKERS: A Review of the Literature

Proliferative Sickle Cell Retinopathy: A Patient and a Physician's Perspective on Quality of Life and Quality of Eye Care

It Ain’t What You Do, It’s the Way that You Do It! Teaching Style Affects Children’s Motivation in Track and Field Lessons

Red Blood Cell Sphericity Index Obtained by Defocusing Microscopy and Retinopathy Severity in Sickle Cell Disease

[THE TREATMENT OF DELIRIUM TREMENS].

Surgical Outcomes In Concurrent Sickle Cell And Diabetic Retinopathy